ESC Professional Premium Access

Adults with congenital heart disease and pulmonary arterial hypertension: Quantitative assessment of haemodynamic parameters under disease targeting therapy - A retrospective multicentre analysis

Congress Presentation

About the speaker

Doctor Philipp von Stein

Cologne University Hospital - Heart Center, Cologne (Germany)
0 follower

6 more presentations in this session

Safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: a prospective cohort study with historical control comparison

Speaker: Doctor A. Kartas (Thessaloniki, GR)

Thumbnail

Dapaglifozin in adults with a systemic right ventricle:initial results from the DAPA-SERVE trial

Speaker: Doctor M. Abbate (Naples, IT)

Thumbnail

Prognostic value and determinants of high sensitive cardiac Troponin levels in patients with a systemic right ventricle: insights from the SERVE-Trial

Speaker: Doctor F. Ruperti Repilado (Basel, CH)

Thumbnail

Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease

Speaker: Doctor R. Luna (Barcelona, ES)

Thumbnail

Efficacy of intravenous iron therapy compared to usual treatment in iron deficient adult cyanotic congenital heart disease patients for improvement in clinical outcomes at three months

Speaker: Assistant Professor Z. Abdullah (New Delhi, IN)

Thumbnail

Access the full session

Pharmacotherapy and biomarkers in adult congenital heart disease: do the same rules apply?

Speakers: Doctor P. von Stein, Doctor A. Kartas, Doctor M. Abbate, Doctor F. Ruperti Repilado, Doctor R. Luna...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by